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Abstract: 
Objective:  To compare the effect of ozone and hyaluronic acid for pain relief in patients of knee osteoarthritis.  
Study Design: Randomized clinical trial. Place of study: Study was conducted in the Pain Managment department 
of the Bahawal Victoria Hospital, Bahawalpur over a period of January, 2018 to January, 2019. Duration of study: 
study was completed in one year from February 2016 to February 2017. Methodology: A total of 200 patients were 
included in the study through non probability consecutive sampling and divided into two groups (A and B) through 
lottery method. Collected data was entered and analyzed by using SPSS version 24, mean and standard deviation 
were calculated for numerical data like age, and Visual Analog Scale (VAS scale) and Western Ontario and 
McMaster Universities Osteoarthritis Index (WOMAC score). Frequency and numbers were calculated for 
qualitative data like gender. Paired t-test and chi square test were applied to see significance of data, p-value less 
than or equal to 0.05 was considered as significant. Results: Mean age, BMI, WOMAC and VAS of ozone 
therapy’s patients was 55.85±4.56 years, 26.01±1.75 kg/m2, 42.23±7.30 and 7.35±1.90 respectively. Mean VAS, 
WOMAC pain, WOMAC stiffness, WOMAC function and WOMAC total of the HA therapy’s (before) patients 
was 6.62±2.25, 8.62±1.89, 1.91±1.08, 27.59±2.64 and 37.67±4.06 respectively. While, the mean VAS, WOMAC 
pain, WOMAC stiffness, WOMAC function and WOMAC total of the HA therapy’s (after) patients was 
3.08±1.68, 2.97±1.21, 1.0±0.48, 13.36±2.39 and 17.40±3.64 respectively. According to paired sample t test, the 
difference was statistically significant at (p<0.05).Conclusion: Results of our study concluded that ozone oxygen 
and hyalorunic acid is equally effective for relieve of pain in knee osteoarthritis. There was no significant 
difference among groups which shows that no drug have superiority on each other. 
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Introduction: 
Osteoarthritis of knee joint is a degenerative disorder which becomes progressive and worse with the passage of 
time. Mechanical forces against the Joint are main cause of this disorder which leads into pain and reduction in 
joint movement1. Women with more than 50 years of age and obesity are more prone to disease than other 
population. Prevalence of OA varies region to region2. According to a survey conducted in 2009 OA is the 4th main 
cause of hospitalization and cost of its management is a huge burden on national economy ($ 42.3 million per 
annum)3. 
Symptoms of OA are stiffness, pain, crepitus, swellingthat ends with deformity of joints. Clinical symptoms are 
very helpful for the diagnosis of OA. There is no definite treatment option available for OA, use of acetaminophen, 
non steroidal anti inflammatory drugs, topical patch, local use of cream is in practice to reduce pain and enhance 
the mobility4. Despite many non pharmacological treatments also available to reduce the symptoms including life 
style modifications, exercise, laser, assisted devices and some physical agent modalities. Surgery is a definite 
treatment available5. 
Patients who are not eligible for surgery and pharmacological treatment various intra articular injections are also 
useful6. Intra articular injection may include normal saline, platelet rich plasma, corticosteroids, phototherapy, 
dextrose, ozone and hyaluronic acid. A natural mucopolysaccharideis found in synovial joint which become 
diminished after development of OA. Effect of hyaluronic acid injection is anti inflammatory and viscoelastic and 
its use in OA pain is a topic of interest for new and non pharmacological research on OA treatment7, 8. 
Many studies and clinical trials were conducted on use of ozone and hyalorunic acid use in lambosacral disc 
herniation, shoulder disorders and failed back surgeries. Ozone also have good effects for relief of pain in traumatic 
meniscal injuries9. In study conducted Mishra et al efficiency of ozone was described as good when compared 
other steroid injections10. Its and efficacy is also proved. 
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Number of studies was conducted on this topic worldwide but no local study available before; this study will fulfill 
the gap of local references. In this study our aim was to compare the effects of ozone therapy versus hyaluronic 
acid (HA) intra-articular injection in knee OA patients. 
 
Methodology: 
This randomized clinical trial was conducted in the Pain Managment department of the Bahawal Victoria Hospital, 
Bahawalpur over a period of January, 2018 to January, 2019. Written informed consent was obtained from 
participants and study was approved by hospital ethical committee. Patients with history of knee pain, pain 
aggravated on weight bearing, age limit 45 to 75 years, either gender and failed conservative treatment were 
enrolled in the study. Patients with history of trauma, injury to affected joint, abnormal coagulation and deranged 
blood count were excluded from the study. 
Total number of patients was divided into two groups (A and B). Non probability consecutive sampling technique 
was adopted and sample size was calculated through WHO sample size calculator woth 95% Ci and 80% study 
power. Group A patients were injected with ozone (10cc) in affected knee. Ozone was injected in combination of 
ozone and oxygen solution (30 ug/mL concentration). Similarly in group B hylorunic acid was injected as 
20mg/mL solution of HA (molecular weight of 500-730 kDa). In both groups before injecting the experiment 
drugs 2cc of 2% of lidocaine was injected in knee in flexed position with the help of 22 G needle. Injections were 
given on weekly basis till three weeks by and expert physician having 15 year experience in field of 
musculoskeletal injections.According to the need of patients’ ice packing and rest upto 48 hours was advised to 
the patients after injection. Modifications in knee movements were also advised to patients along with some 
exercises like hamstring stretching and isometric quadriceps strengthening exercises. 
Patients were evaluated before and after 6 months of treatment given with visual analogue score scale and 
WOMAC scoring system. Pain assessment was done by consultant who was blinded of study. WOMAC score was 
ranging from 0 to 4: 0 score means no pain and restriction, 1 score mean mild pain and restriction, 2 score means 
moderate pain and restriction, 3 score means severe pain and restriction and score 4 means very severe pain and 
restriction. 
Collected data was entered and analyzed by using SPSS version 24, mean and standard deviation were calculated 
for numerical data like age, and VAS scale and WOMAC score. Frequency and numbers were calculated for 
qualitative data like gender. Student t-test and chi square test were applied to see significance of data, P value less 
than or equal to 0.05 was considered as significant.  
 
Results: 
 A total number of 200 patients were enrolled in this study, both genders. The study patients were further 
divided into two equal groups i.e. Ozone and HA respectively. The mean age, BMI, WOMAC and VAS of ozone 
therapy’s patients was 55.85±4.56 years, 26.01±1.75 kg/m2, 42.23±7.30 and 7.35±1.90 respectively. OA grade II 
and III was observed as (59%) n=59 and (41%) n=41 respectively. There were (56%) n=56 males and (44%) n=44 
females. While, the mean age, BMI, WOMAC and VAS of HA therapy’s patients was 55.98±3.78 years, 
27.46±1.14 kg/m2, 38.35±4.14 and 6.88±1.25 respectively. OA grade II and III was observed as (54%) n=54 and 
(46%) n=46 respectively. There were (55%) n=55 males and (45%) n=45 females. The difference was statistically 
significant of BMI (p=0.000), VAS (p=0.040) and WOMAC (p=0.000) with regards to groups. (Table. I). 
 The mean VAS, WOMAC pain, WOMAC stiffness, WOMAC function and WOMAC total of the ozone 
therapy’s (before) patients was 6.91±2.49, 9.24±1.54, 2.28±1.0, 28.19±5.07 and 41.49±9.93 respectively. While, 
The mean VAS, WOMAC pain, WOMAC stiffness, WOMAC function and WOMAC total of the ozone therapy’s 
(after) patients was 2.75±1.92, 3.10±1.45, 1.30±0.95, 15.68±4.10 and 20.68±4.83 respectively. According to 
paired sample t test, the difference was statistically significant at (p<0.05). (Table. II). 
 The mean VAS, WOMAC pain, WOMAC stiffness, WOMAC function and WOMAC total of the HA 
therapy’s (before) patients was 6.62±2.25, 8.62±1.89, 1.91±1.08, 27.59±2.64 and 37.67±4.06 respectively. While, 
the mean VAS, WOMAC pain, WOMAC stiffness, WOMAC function and WOMAC total of the HA therapy’s 
(after) patients was 3.08±1.68, 2.97±1.21, 1.0±0.48, 13.36±2.39 and 17.40±3.64 respectively. According to paired 
sample t test, the difference was statistically significant at (p<0.05). (Table. III). 
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 The mean VAS, WOMAC pain, WOMAC stiffness, WOMAC function and WOMAC total of the Ozone 
and HA therapy’s (after) patients was presented in (Table IV). The difference was statistically insignificant.  
Table. I 
Demographic and baseline characteristics among both the groups  
Characteristics Ozone 
(n=100) 
HA 
(n=100) 
P value 
Age 55.85±4.56 55.98±3.78 0.826 
Gender 
Male (56%) n=56 (55%) n=55 0.090 
Female (44%) n=44 (45%) n=45 
Total  (100%) n=100 (100%) n=100 
BMI (kg/m2) 26.01±1.75 27.46±1.14 <0.001 
WOMAC 42.23±7.30 38.35±4.14 <0.001 
VAS 7.35±1.90 6.88±1.25 0.040 
OA Grade 
II (59%) n=59 (54%) n=54 0.476 
III (41%) n=41 (46%) n=46 
Total (100%) n=100 (100%) n=100 
 
Table. II 
VAS and WOMAC scores of ozone group at the 6th month after injection 
Characteristics Ozone therapy 
(before)  
(n=100) 
Ozone therapy  
(after)  
(n=100) 
P value  
VAS 6.91±2.49 2.75±1.92 <0.001 
WOMAC pain 9.24±1.54 3.10±1.45 <0.001 
WOMAC stiffness 2.28±1.0 1.30±0.95 <0.001 
WOMAC Function 28.19±5.07 15.68±4.10 <0.001 
WOMAC Total 41.49±9.93 20.68±4.83 <0.001 
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Table. III 
VAS and WOMAC scores of HA group at the 6th month after injection 
Characteristics HA therapy 
 (Before) 
(n=100) 
HA therapy  
(after) 
(n=100) 
Test of Sig. 
VAS 6.62±2.25 3.08±1.68 <0.001 
WOMAC pain 8.62±1.89 2.97±1.21 <0.001 
WOMAC stiffness 1.91±1.08 1.0±0.48 <0.001 
WOMAC Function 27.59±2.64 13.36±2.39 <0.001 
WOMAC Total 37.67±4.06 17.40±3.64 <0.001 
 
Table. IV 
Difference of  
Characteristics Ozone therapy 
(after)  
(n=100) 
HA therapy  
(after)  
(n=100) 
P value 
VAS 2.75±1.92 3.08±1.68 0.172 
WOMAC pain 3.10±1.45 2.97±1.21 0.894 
WOMAC stiffness 1.30±0.95 1.0±0.48 0.288 
WOMAC Function 15.68±4.10 13.36±2.39 0.827 
WOMAC Total 20.68±4.83 17.40±3.64 0.218 
 
 
Discussion: 
In accordance with our results both drugs ozone and hyaluronic acid are equally effective no outcome variable 
have superiority over other. Some previous studies also document benefits of these both drugs. In a study 
conducted by Ahmed A. Al-Jaziri et al 11 reported that ozone plus oxygen in combination have anti inflammatory 
and pain killing effects when administered in cases of osteoarthritis of spine and joints. Its mechanism of action 
and histological changes after intra articular injection is also proved.  
In another study conducted by Seyman D et al12 reported that in cases of septic arthritis ozone injection is also 
beneficial. He demonstrated that ozone therapy is cost effective and its effective is now globally accepted. 
Rodriguez-Merchan et al13 conducted a study on this topic and use hyaluronic acid for intra articular medicine. 
He reported that use of hyaluronic acid recommended as five intra articular injections in a week before surgical 
intervention is a useful technique. 
Raeissadat SA et al14 also conducted a randomized control trial between hyaluronic acid and ozone oxygen in 
patients of knee osteoarthritis and reported that both drugs are equally effective no one have superiority over other 
drug in any specific aspect. Six month follow up shows no superiority of both drugs on each other.  
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal DOI: 10.7176/JMPB 
Vol.52, 2019 
 
105 
Another trial was conducted in 2014 between ozone and hyalorunic acid by Momen Zadeh S et al15. Results of his 
study revealed that there was no mark able difference among groups on short follow up but a strong improvement 
was observed in both groups from baseline VAS score and WOMAC score. These results are compareable with 
our results. Another study was conducted in Turkey by Duymus TM et al16 and compared three groups ozone, HA 
and PRP and reported that HA have more better results as compared to PRP and ozone injection. 
In another study conducted by Peter Jüni et al17 on comparison of Hylan and HA and observed some significant 
difference in hylan group but due to its cost and availability limits its use in our region. Similarly Kilincoglu V et 
al18 conducted a study in comparison of HA and platelet rich plasma and reported that PRP have lot of benefits 
over HA. Because plasma was drained from patients own blood so it has minimum risk of reaction and blood borne 
diseases. PRP is also more efficient than HA.  
Kon E et al19 and Filardo G et al20 also conducted studies on comparison of PRP and HA Autologus PRP injections 
achieved more precise and controlled results as compare to HA and it is concluded that PRP is also cost effective 
with minimum complication chances when administered in knee OA. Results of these studies can be compared 
our results and study conclusion.  
 
Conclusion 
Results of our study concluded that ozone oxygen and hyalorunic acid is equally effective for relieve of pain in 
knee osteoarthritis. There was no significant difference among groups which shows that no drug have superiority 
on each other. 
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